Last $57.89 USD
Change Today +0.56 / 0.99%
Volume 3.6M
MYL On Other Exchanges
As of 8:10 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by MYLAN NV (MYL) in the last 6 months

Announced 01/30/15
30.00M for Theravance Biopharma, Inc.
Private Placement

Theravance Biopharma, Inc. (NasdaqGM:TBPH) announced that it has entered into an ordinary share purchase agreement for a private placement of 1,585,790 ordinary shares at a price of $18.918 per share for gross proceeds of $29,999,975.22 with new investor Mylan, Inc. on January 30, 2015. The shares will be issued at premium. The company expects to close the transaction on February 2, 2015. The company will not pay any underwriting discounts or commissions.

MYL's price was unchanged after the transaction was announced on 01/30/15.
Investor / Buyer
Mylan, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYL:US $57.89 USD +0.56

MYL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $148.04 USD +1.32
Hospira Inc $87.67 USD +0.13
Omnicare Inc $76.31 USD -0.43
Perrigo Co PLC $157.55 USD +3.08
WW Grainger Inc $239.20 USD +2.29
View Industry Companies

Industry Analysis


Industry Average

Valuation MYL Industry Range
Price/Earnings 24.7x
Price/Sales 2.9x
Price/Book 6.3x
Price/Cash Flow 23.3x
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYLAN NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at